The Senate Commerce and Consumer Affairs committee met in executive session and advanced a large slate of bills, placing most items on the consent calendar; several measures passed unanimously or by lopsided margins, one bill (children's mental health Medicaid assessment) was tabled pending an amendment, and PBM/drug pricing drew opposition and a planned minority report.